Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in L'Asparaginase-induced antithrombin III deficiency

L Mitchell, H Hoogendoorn, AR Giles, P Vegh, M Andrew

Blood (1994) 83 (2): 386–391.

https://doi.org/10.1182/blood.V83.2.386.386

Published: 1994

Journal Articles

Biochemical, immunological, and in vivo functional characterization of B-domain-deleted factor VIII

DD Pittman, EM Alderman, KN Tomkinson, JH Wang, AR Giles, RJ Kaufman

Blood (1993) 81 (11): 2925–2935.

https://doi.org/10.1182/blood.V81.11.2925.2925

Published: 1993

Journal Articles

Anticoagulant and fibrinolytic activities are promoted, not retarded, in vivo after thrombin generation in the presence of a monoclonal antibody that inhibits activation of protein C

FB Jr Taylor, H Hoogendoorn, AC Chang, G Peer, ME Nesheim, R Catlett, DC Stump, AR Giles

Blood (1992) 79 (7): 1720–1728.

https://doi.org/10.1182/blood.V79.7.1720.1720

Published: 1992

Journal Articles

Alpha 2-macroglobulin binds and inhibits activated protein C

H Hoogendoorn, CH Toh, ME Nesheim, AR Giles

Blood (1991) 78 (9): 2283–2290.

https://doi.org/10.1182/blood.V78.9.2283.2283

Published: 1991

Journal Articles

Cosegregation of von Willebrand factor gene polymorphisms and possible germinal mosaicism in type IIB von Willebrand disease

EW Murray, AR Giles, PJ Bridge, IR Peake, DP Lillicrap

Blood (1991) 77 (7): 1476–1483.

https://doi.org/10.1182/blood.V77.7.1476.1476

Published: 1991

Journal Articles

A qualitative and quantitative analysis of the activation and inactivation of protein C in vivo in a primate model

H Hoogendoorn, ME Nesheim, AR Giles

Blood (1990) 75 (11): 2164–2171.

https://doi.org/10.1182/blood.V75.11.2164.2164

Published: 1990

Journal Articles

In vivo characterization of recombinant factor VIII in a canine model of hemophilia A (factor VIII deficiency)

AR Giles, S Tinlin, H Hoogendoorn, MA Fournel, P Ng, N Pancham

Blood (1988) 72 (1): 335–339.

https://doi.org/10.1182/blood.V72.1.335.335

Published: 1988

Journal Articles

In vivo studies of the role of factor VII in hemostasis

AR Giles, S Tinlin, L Brosseau, H Hoogendoorn

Blood (1985) 65 (5): 1197–1200.

https://doi.org/10.1182/blood.V65.5.1197.1197

Published: 1985

Journal Articles

Development of factor VIII:C antibodies in dogs with hemophilia A (factor VIII:C deficiency)

AR Giles, S Tinlin, H Hoogendoorn, P Greenwood, R Greenwood

Blood (1984) 63 (2): 451–456.

https://doi.org/10.1182/blood.V63.2.451.451

Published: 1984

Journal Articles

A canine model of hemophilic (factor VIII:C deficiency) bleeding

AR Giles, S Tinlin, R Greenwood

Blood (1982) 60 (3): 727–730.

https://doi.org/10.1182/blood.V60.3.727.727

Published: 1982

Journal Articles

The coagulant-active phospholipid content is a major determinant of in vivo thrombogenicity of prothrombin complex (Factor IX) concentrates in rabbits

AR Giles, ME Nesheim, H Hoogendoorn, PB Tracy, KG Mann

Blood (1982) 59 (2): 401–407.

https://doi.org/10.1182/blood.V59.2.401.401

Published: 1982

Journal Articles

Drug-induced thrombocytopenia is associated with increased binding of IgG to platelets both in vivo and in vitro

JG Kelton, D Meltzer, J Moore, AR Giles, WE Wilson, R Barr, J Hirsh, PB Neame, PJ Powers, I Walker, F Bianchi, CJ Carter

Blood (1981) 58 (3): 524–529.

https://doi.org/10.1182/blood.V58.3.524.524

Published: 1981

Journal Articles

Comparison of two direct assays for platelet-associated IgG (PAIgG) in assessement of immune and nonimmune thrombocytopenia

JG Kelton, AR Giles, PB Neame, P Powers, N Hageman, J Hirsch

Blood (1980) 55 (3): 424–429.

https://doi.org/10.1182/blood.V55.3.424.424

Published: 1980

NARROW

Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in L'Asparaginase-induced antithrombin III deficiency

Biochemical, immunological, and in vivo functional characterization of B-domain-deleted factor VIII

Anticoagulant and fibrinolytic activities are promoted, not retarded, in vivo after thrombin generation in the presence of a monoclonal antibody that inhibits activation of protein C

Alpha 2-macroglobulin binds and inhibits activated protein C

Cosegregation of von Willebrand factor gene polymorphisms and possible germinal mosaicism in type IIB von Willebrand disease

A qualitative and quantitative analysis of the activation and inactivation of protein C in vivo in a primate model

In vivo characterization of recombinant factor VIII in a canine model of hemophilia A (factor VIII deficiency)

In vivo studies of the role of factor VII in hemostasis

Development of factor VIII:C antibodies in dogs with hemophilia A (factor VIII:C deficiency)

A canine model of hemophilic (factor VIII:C deficiency) bleeding

The coagulant-active phospholipid content is a major determinant of in vivo thrombogenicity of prothrombin complex (Factor IX) concentrates in rabbits

Drug-induced thrombocytopenia is associated with increased binding of IgG to platelets both in vivo and in vitro

Comparison of two direct assays for platelet-associated IgG (PAIgG) in assessement of immune and nonimmune thrombocytopenia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only